$270 Million is the total value of Foresite Capital Management II, LLC's 10 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AERI | Aerie Pharmaceuticals, Inc. | $90,155,000 | -8.9% | 1,464,749 | 0.0% | 33.37% | -4.3% | |
| AIMT | Sell | Aimmune Therapeutics, Inc. | $90,046,000 | -0.2% | 3,300,797 | -1.7% | 33.32% | +4.8% |
| ALDR | Sell | Alder BioPharmaceuticals, Inc. | $26,411,000 | -0.9% | 1,586,220 | -5.9% | 9.77% | +4.1% |
| INSM | Insmed Incorporated | $19,566,000 | -14.5% | 967,636 | 0.0% | 7.24% | -10.2% | |
| EPZM | Sell | Epizyme, Inc. | $15,183,000 | -23.7% | 1,432,364 | -2.4% | 5.62% | -19.8% |
| XLRN | Sell | Acceleron Pharma Inc. | $12,606,000 | +6.1% | 220,268 | -10.0% | 4.66% | +11.5% |
| ADAP | Sell | Adaptimmune Therapeutics PLCsponds adr | $6,780,000 | -18.4% | 500,000 | -28.6% | 2.51% | -14.3% |
| DNLI | Denali Therapeutics Inc. | $5,435,000 | +42.5% | 250,000 | 0.0% | 2.01% | +49.7% | |
| BDSI | Buy | BioDelivery Sciences International, Inc. | $2,658,000 | +2853.3% | 949,233 | +3012.2% | 0.98% | +2975.0% |
| SGMO | Sangamo Therapeutics, Inc. | $1,364,000 | +19.3% | 80,500 | 0.0% | 0.50% | +25.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Epizyme, Inc. | 29 | Q4 2021 | 11.9% |
| Acceleron Pharma Inc. | 24 | Q3 2021 | 4.8% |
| Aerie Pharmaceuticals, Inc. | 22 | Q1 2020 | 40.3% |
| 10x Genomics, Inc. | 17 | Q3 2023 | 100.0% |
| Aimmune Therapeutics, Inc. | 17 | Q3 2019 | 41.0% |
| Alder BioPharmaceuticals, Inc. | 16 | Q3 2019 | 12.6% |
| Zafgen, Inc. | 12 | Q3 2017 | 33.5% |
| BioDelivery Sciences International, Inc. | 12 | Q1 2019 | 3.2% |
| Insmed Incorporated | 11 | Q1 2020 | 13.8% |
| Adaptimmune Therapeutics PLC | 9 | Q4 2018 | 11.3% |
View Foresite Capital Management II, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-16 |
View Foresite Capital Management II, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.